## Abstract ## Background Surgery for recurrent parotid pleomorphic adenoma is a challenging problem. ## Methods One hundred eight patients who underwent 134 reoperations for recurrent parotid pleomorphic adenoma (followβup, 22 years) were evaluated for histopathologic features and risk factors
Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: A clinical analysis of 52 patients
β Scribed by Afina S. Glas; Albert Vermey; Harry Hollema; Peter H. Robinson; Jan L.N. Roodenburg; Raoul E. Nap; John Th. M. Plukker
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 97 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1043-3074
- DOI
- 10.1002/hed.1036
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
Surgical management of recurrent pleomorphic adenoma of the parotid gland has a considerable risk of facial nerve injury and a high reβrecurrence rate. To obtain more insight into this issue we evaluated our experiences.
Methods
Medical records and histologic material of all these patients (31 women and 21 men), who had been treated from 1976β1995 were reviewed. Median interval between initial treatment and commencement of recurrences was 3 (0.8β18) years. Last surgery consisted of parotidectomy in 48 patients (92%), including 19 (40%) total procedures and wide local excision with involved skin in four patients.
Results
At a median followβup of 9 years, eight patients (8/52; 15%) had reβrecurrences develop, including 4 of 21 patients (19%) after a previous parotidectomy (group I) and 4 of 31 patients (13%) without prior parotidectomy (group II). The chance of reβrecurrence in a group of patients with a minimal followβup of 10 years after salvage surgery was 17% (4 of 24). The risk of a new relapse was, respectively, 4% and 8% at 1 and 5 years after treatment of recurrent disease. Acceptable N.VII function was preserved in 45 of the 49 (92%) nerves at risk. The risk of N.VII injuy was higher and more serious in group I (29% vs 10% in group II). The function of four of the five (80%) reconstructed zygomaticotemporal branches of the N.VII was adequate.
Conclusion
Surgical treatment of recurrent pleomorphic adenoma of the parotid gland, usually consisting of a parotidectomy with wide extent and eventually facial nerve reconstruction, demonstrates favorable results with acceptable morbidity. The risk of new relapse and N.VII injury was higher after previous parotidectomy. Β© 2001 John Wiley & Sons, Inc. Head Neck 23: 311β316, 2001.
π SIMILAR VOLUMES
The remainder of the examination is unremarkable. Fine-needle aspiration of the mass confirms pleomorphic adenoma which is consistent with the pathology of the original tumor.
## Abstract ## Background. Pleomorphic adenoma constitutes the most common benign parotid gland tumor. Local recurrence after surgical treatment (lateral or total parotidectomy) has been described in 1% to 5% of cases. Malignant degeneration has been reported in 2% to 9% of cases of pleomorphic ad